Galectin Therapeutics Inc... (GALT)
NASDAQ: GALT
· Real-Time Price · USD
4.61
-0.14 (-2.95%)
At close: Sep 25, 2025, 3:59 PM
4.98
8.03%
After-hours: Sep 25, 2025, 05:23 PM EDT
-2.95% (1D)
| Bid | 3.37 |
| Market Cap | 295.28M |
| Revenue (ttm) | 36K |
| Net Income (ttm) | -40.34M |
| EPS (ttm) | -0.64 |
| PE Ratio (ttm) | -7.2 |
| Forward PE | -10.93 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 5.82 |
| Volume | 215,927 |
| Avg. Volume (20D) | 398,124.2 |
| Open | 4.72 |
| Previous Close | 4.75 |
| Day's Range | 4.45 - 4.88 |
| 52-Week Range | 0.73 - 6.55 |
| Beta | 0.87 |
| Ex-Dividend Date | n/a |
About GALT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GALT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GALT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+60.4%
Galectin Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
5 months ago
-19.74%
Galectin Therapeutics shares are trading lower following a FY24 EPS miss.
